Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GCAP1 Antikörper (C-Term)

Der Kaninchen Polyklonal Anti-GCAP1-Antikörper wurde für WB und IHC validiert. Er ist geeignet, GCAP1 in Proben von Human zu detektieren.
Produktnummer ABIN2798879

Kurzübersicht für GCAP1 Antikörper (C-Term) (ABIN2798879)

Target

Alle GCAP1 (GUCA1A) Antikörper anzeigen
GCAP1 (GUCA1A) (Guanylate Cyclase Activator 1A (Retina) (GUCA1A))

Reaktivität

  • 20
  • 18
  • 17
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 34
  • 1
Kaninchen

Klonalität

  • 34
  • 1
Polyklonal

Konjugat

  • 12
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser GCAP1 Antikörper ist unkonjugiert

Applikation

  • 29
  • 17
  • 13
  • 13
  • 9
  • 6
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Bindungsspezifität

    • 15
    • 8
    • 5
    • 3
    • 1
    • 1
    • 1
    AA 160-191, C-Term

    Verwendungszweck

    Rabbit Anti-Human GCAP1 (C-term) Antibody

    Immunogen

    This GCAP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 160-191 amino acids from the C-terminal region of human GCAP1.

    Isotyp

    Ig Fraction
  • Applikationshinweise

    Western Blot, Immunohistochemistry
    Recommended Dilutions
    WB: 1:1000, IHC: 1:50-100The anti-GCAP1 C-term Pab is used in Western blot to detect GCAP1 in Y79 cell lysate.
    Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry, clinical relevance has not been evaluated. BC = breast carcinoma, HC = hepatocarcinoma.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    2.0 mg/mL

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    2-8°C (short-term), -20°C (long-term)
  • Target

    GCAP1 (GUCA1A) (Guanylate Cyclase Activator 1A (Retina) (GUCA1A))

    Andere Bezeichnung

    GCAP1

    Hintergrund

    Target Description: Guanylate cyclase-activating protein is a l Ca(2+)-binding protein that upregulates synthesis of cGMP in photoreceptors. The known mammalian GCAPs are more than 90 % similar, consisting of 201 to 205 amino acids, and containing 3 identically conserved Ca(2+)-binding sites. The GUCA1A gene, also termed GCAP1, is transcribed into a single 1.7-kb mRNA species detectable only in the retina. In a 4-generation British family with typical clinical features of autosomal dominant cone dystrophy a tyr99-to-cys mutation) in the GUCA1A gene has been identified. Another family with a pro50-to-leu mutation in GUCA1A demonstrated phenotypic variability ranging from mild photophobia to rod-cone dystrophy. The mutant protein could activate guanylate cyclase 1 (GUCY2D) and displayed similar calcium sensitivity to wildtype protein. However, there was a marked increase in the susceptibility to protease degradation and a reduction in the thermal stability of the pro50-to-leu mutation, which may depress cellular concentration and thereby contribute to retinal cell mortality.

    Gene Symbol: GUCA1A

    Molekulargewicht

    22920 Da

    Gen-ID

    2978

    UniProt

    P43080

    Pathways

    Regulation of G-Protein Coupled Receptor Protein Signaling, Phototransduction
Sie sind hier:
Chat with us!